Reasons in favour of universal vaccination campaign against COVID-19 in the pediatric population
Abstract Background Despite the growing evidence of the extreme efficacy of COVID-19 vaccines in adults and the elderly, the administration of the same prophylactic measures to pediatric subjects is debated by some parents and by a number of researchers. The aim of this manuscript is to explain the...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-01-01
|
| Series: | Italian Journal of Pediatrics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13052-021-01192-4 |
| _version_ | 1798026502118309888 |
|---|---|
| author | Nicola Principi Susanna Esposito |
| author_facet | Nicola Principi Susanna Esposito |
| author_sort | Nicola Principi |
| collection | DOAJ |
| description | Abstract Background Despite the growing evidence of the extreme efficacy of COVID-19 vaccines in adults and the elderly, the administration of the same prophylactic measures to pediatric subjects is debated by some parents and by a number of researchers. The aim of this manuscript is to explain the reasons for overcoming hesitancy towards COVID-19 vaccination in children and adolescents and to highlight the importance of universal COVID-19 vaccination in the pediatric population. Main findings Recent epidemiological data suggest that the risk that a child with COVID-19 is hospitalized or admitted to the pediatric intensive care unit is greater than initially thought. Children may also suffer from long COVID and school closure because of COVID-19 can cause relevant mental health problems in the pediatric population. Placebo-controlled, observer-blinded, clinical trials showed appropriate efficacy, safety and tolerability of authorized mRNA COVID-19 vaccines in children and adolescents 12–17 years old. Vaccination in children younger than 12 years of age will allow further benefits . Conclusions COVID-19 vaccine administration seems mandatory in all the children and adolescents because of COVID-19 related complications as well as the efficacy, safety and tolerability of COVID-19 vaccines in this population. Due to the recent approval of COVID-9 vaccines for children 5–10 years old, it is desirable that vaccine opponents can understand how important is the universal immunization against COVID-19 for the pediatric subjects. |
| first_indexed | 2024-04-11T18:36:27Z |
| format | Article |
| id | doaj.art-73fc86de6562405cb71c5ed8d0a1e1bf |
| institution | Directory Open Access Journal |
| issn | 1824-7288 |
| language | English |
| last_indexed | 2024-04-11T18:36:27Z |
| publishDate | 2022-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Italian Journal of Pediatrics |
| spelling | doaj.art-73fc86de6562405cb71c5ed8d0a1e1bf2022-12-22T04:09:15ZengBMCItalian Journal of Pediatrics1824-72882022-01-014811510.1186/s13052-021-01192-4Reasons in favour of universal vaccination campaign against COVID-19 in the pediatric populationNicola Principi0Susanna Esposito1Università degli Studi di MilanoPietro Barilla Children’s Hospital, Department of Medicine and Surgery, University of ParmaAbstract Background Despite the growing evidence of the extreme efficacy of COVID-19 vaccines in adults and the elderly, the administration of the same prophylactic measures to pediatric subjects is debated by some parents and by a number of researchers. The aim of this manuscript is to explain the reasons for overcoming hesitancy towards COVID-19 vaccination in children and adolescents and to highlight the importance of universal COVID-19 vaccination in the pediatric population. Main findings Recent epidemiological data suggest that the risk that a child with COVID-19 is hospitalized or admitted to the pediatric intensive care unit is greater than initially thought. Children may also suffer from long COVID and school closure because of COVID-19 can cause relevant mental health problems in the pediatric population. Placebo-controlled, observer-blinded, clinical trials showed appropriate efficacy, safety and tolerability of authorized mRNA COVID-19 vaccines in children and adolescents 12–17 years old. Vaccination in children younger than 12 years of age will allow further benefits . Conclusions COVID-19 vaccine administration seems mandatory in all the children and adolescents because of COVID-19 related complications as well as the efficacy, safety and tolerability of COVID-19 vaccines in this population. Due to the recent approval of COVID-9 vaccines for children 5–10 years old, it is desirable that vaccine opponents can understand how important is the universal immunization against COVID-19 for the pediatric subjects.https://doi.org/10.1186/s13052-021-01192-4COVID-19COVID-19 vaccinePediatric infectious diseaseSARS-CoV-2 |
| spellingShingle | Nicola Principi Susanna Esposito Reasons in favour of universal vaccination campaign against COVID-19 in the pediatric population Italian Journal of Pediatrics COVID-19 COVID-19 vaccine Pediatric infectious disease SARS-CoV-2 |
| title | Reasons in favour of universal vaccination campaign against COVID-19 in the pediatric population |
| title_full | Reasons in favour of universal vaccination campaign against COVID-19 in the pediatric population |
| title_fullStr | Reasons in favour of universal vaccination campaign against COVID-19 in the pediatric population |
| title_full_unstemmed | Reasons in favour of universal vaccination campaign against COVID-19 in the pediatric population |
| title_short | Reasons in favour of universal vaccination campaign against COVID-19 in the pediatric population |
| title_sort | reasons in favour of universal vaccination campaign against covid 19 in the pediatric population |
| topic | COVID-19 COVID-19 vaccine Pediatric infectious disease SARS-CoV-2 |
| url | https://doi.org/10.1186/s13052-021-01192-4 |
| work_keys_str_mv | AT nicolaprincipi reasonsinfavourofuniversalvaccinationcampaignagainstcovid19inthepediatricpopulation AT susannaesposito reasonsinfavourofuniversalvaccinationcampaignagainstcovid19inthepediatricpopulation |